Logo image of INCR

INTERCURE LTD (INCR) Stock Overview

NASDAQ:INCR - IL0011063760 - Common Stock

1.58 USD
+0 (+0.27%)
Last: 9/5/2025, 8:22:38 PM

INCR Key Statistics, Chart & Performance

Key Statistics
52 Week High2.07
52 Week Low1.17
Market Cap86.13M
Shares54.51M
Float40.27M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.44
PEN/A
Fwd PE8.91
Earnings (Next)N/A N/A
IPO07-26 2007-07-26
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


INCR short term performance overview.The bars show the price performance of INCR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 4 -4 6

INCR long term performance overview.The bars show the price performance of INCR in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40 -60

The current stock price of INCR is 1.58 USD. In the past month the price increased by 6.04%. In the past year, price decreased by -22.55%.

INTERCURE LTD / INCR Daily stock chart

INCR Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 45.03 688.28B
JNJ JOHNSON & JOHNSON 17.84 429.72B
AZN ASTRAZENECA PLC-SPONS ADR 18.4 253.31B
NVS NOVARTIS AG-SPONSORED ADR 14.66 251.14B
NVO NOVO-NORDISK A/S-SPONS ADR 14.13 245.41B
MRK MERCK & CO. INC. 11 211.59B
PFE PFIZER INC 7.34 141.46B
SNY SANOFI-ADR 10.47 113.41B
BMY BRISTOL-MYERS SQUIBB CO 7 95.95B
GSK GSK PLC-SPON ADR 8.96 81.59B
ZTS ZOETIS INC 24.65 67.95B
TAK TAKEDA PHARMACEUTIC-SP ADR 53.1 48.64B

About INCR

Company Profile

INCR logo image InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Company Info

INTERCURE LTD

Medinat HaYehudim 85

Herzliya 27604 IL

CEO: Alistair Macdonald

Employees: 320

INCR Company Website

INCR Investor Relations

Phone: 972774605012

INTERCURE LTD / INCR FAQ

What is the stock price of INTERCURE LTD today?

The current stock price of INCR is 1.58 USD. The price increased by 0.27% in the last trading session.


What is the ticker symbol for INTERCURE LTD stock?

The exchange symbol of INTERCURE LTD is INCR and it is listed on the Nasdaq exchange.


On which exchange is INCR stock listed?

INCR stock is listed on the Nasdaq exchange.


What is INTERCURE LTD worth?

INTERCURE LTD (INCR) has a market capitalization of 86.13M USD. This makes INCR a Micro Cap stock.


How many employees does INTERCURE LTD have?

INTERCURE LTD (INCR) currently has 320 employees.


What are the support and resistance levels for INTERCURE LTD (INCR) stock?

INTERCURE LTD (INCR) has a support level at 1.5 and a resistance level at 1.6. Check the full technical report for a detailed analysis of INCR support and resistance levels.


Is INTERCURE LTD (INCR) expected to grow?

The Revenue of INTERCURE LTD (INCR) is expected to grow by 39.3% in the next year. Check the estimates tab for more information on the INCR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy INTERCURE LTD (INCR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INTERCURE LTD (INCR) stock pay dividends?

INCR does not pay a dividend.


What is the Price/Earnings (PE) ratio of INTERCURE LTD (INCR)?

INTERCURE LTD (INCR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.44).


What is the Short Interest ratio of INTERCURE LTD (INCR) stock?

The outstanding short interest for INTERCURE LTD (INCR) is 0.09% of its float. Check the ownership tab for more information on the INCR short interest.


INCR Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to INCR. When comparing the yearly performance of all stocks, INCR is a bad performer in the overall market: 83.38% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

INCR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to INCR. INCR has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

INCR Financial Highlights

Over the last trailing twelve months INCR reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS decreased by -8.71% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -8.62%
ROE -14.9%
Debt/Equity 0.23
Chartmill High Growth Momentum
EPS Q2Q%-822.04%
Sales Q2Q%236.68%
EPS 1Y (TTM)-8.71%
Revenue 1Y (TTM)-32.82%

INCR Forecast & Estimates

For the next year, analysts expect an EPS growth of 1550% and a revenue growth 39.3% for INCR


Analysts
Analysts82.86
Price TargetN/A
EPS Next Y1550%
Revenue Next Year39.3%

INCR Ownership

Ownership
Inst Owners5.35%
Ins Owners30.2%
Short Float %0.09%
Short Ratio0.99